EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ypsomed Holding AG's Enterprise Value is CHF5,464.4 Mil.
Ypsomed Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was CHF-32.1 Mil. Therefore, Ypsomed Holding AG's EV-to-FCF for today is -170.30.
The historical rank and industry rank for Ypsomed Holding AG's EV-to-FCF or its related term are showing as below:
XSWX:YPSN'
s EV-to-FCF Range Over the Past 10 Years
Min: -168.38 Med: -27.54 Max: 172.43
Current: -168.38
During the past 13 years, the highest EV-to-FCF of Ypsomed Holding AG was 172.43. The lowest was -168.38. And the median was -27.54.
XSWX:YPSN's EV-to-FCF is ranked worse than 100% of 361
companies
in the Medical Devices & Instruments industry
Industry Median: 28.78
vs XSWX:YPSN: -168.38
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Ypsomed Holding AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ypsomed Holding AG's EV-to-FCF
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's EV-to-FCF falls into.
Ypsomed Holding AG's current Enterprise Value is CHF5,464.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was CHF-32.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (XSWX:YPSN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ypsomed Holding AG's PE Ratio for today is calculated as:
Ypsomed Holding AG's share price for today is CHF387.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was CHF5.740.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ypsomed Holding AG EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Ypsomed Holding AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Ypsomed Holding AG (XSWX:YPSN) Business Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:YPSN has been successfully added to your 